JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B2160 LY2608204

Target: GK

Summary: GK activator

≥28.35 mg/mL
B1250 Ezatiostat hydrochloride

3 Citation

Target: Gutathione S-transferase

Summary: GST inhibitor

≥28.3 mg/mL
C5811 5,8,11-Eicosatriynoic Acid

Summary: nonselective inhibitor of lipoxygenases (12-LO)

≤20 mg/mL
A1001 Adrenomedullin (1-12), human

Summary: Vasodilator

insoluble in EtOH; ≥151.3 mg/mL
A1002 Beta-Amyloid (1-11)

Summary: Amyloidogenic peptide

insoluble in EtOH; ≥132.5 mg/mL
A7004 Boc-ON

≥14.1 mg/mL
A1020 GnRH Associated Peptide (GAP) (1-13), human

Target: prolactin secretion|gonadotropin release

Summary: Inhibitor of prolactin secretion

insoluble in H2O; insoluble in EtOH; ≥74.6 mg/mL
A1035 Papain Inhibitor

Target: Papains

Summary: Inhibitor of peptidase activity of Papain

insoluble in EtOH; ≥45.1 mg/mL
A8790 Cyclo (-RGDfC)

1 Citation

Summary: A cyclic RGD peptide with high affinity for alphavbeta3 that disrupts cell integrin interactions

insoluble in EtOH; insoluble in H2O; ≥49 mg/mL
L1052 DiscoveryProbe™ Clinical & FDA approved Drug Library

Summary: A collection of 2721 clinical & FDA approved drugs supplied as lyophilized powder or pre-dissolved DMSO solutions